Project Grant R21MD020222
Award Date
9/22/24
Completion Date
6/30/26
Dollars Obligated
$489K
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to investigate survivorship trajectories and clinical outcomes for liver transplant recipients. The $365,378 award will fund a 5-year study to: 1) characterize distinct post-liver transplant survivorship phenotypes, 2) examine the relationship between survivorship phenotypes and outcomes like medication adherence...
This federal Project Grant award, valued at $801,832, was provided by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307). The award aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a multi-level integrated intervention that combines lung cancer screening using low-dose computed tomography (LDCT) and smoking cessation efforts. The key goals...
This $533,333.34 federal Project Grant award from the Department of Health and Human Services' Office of Minority Health under the Community Programs to Improve Minority Health (CFDA 93.137) program will support Healthvisions Midwest's "Community Level Innovations for Improving Health Outcomes" (CLIIHO) project. The project aims to address the disproportionate burden of the diabetes epidemic on African American and Hispanic populations in Allen and Lake Counties, Indiana through...
This Project Grant award of $1,601,966, funded by the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research program), supports research to identify situations that increase bias among healthcare providers, which can contribute to health disparities. The University of Arkansas is the prime awardee, with sub-awards to Carilion Medical Center, the University of Texas at San Antonio, Florida State University, and the University of...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $3,794,331 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to the Sloan-Kettering Institute for Cancer Research. The award, effective August 8, 2024 through February 28, 2029, will fund a study comparing three technology-enabled medical interpretation modalities - remote simultaneous, remote consecutive audio, and remote consecutive video - to improve cancer care...
This Project Grant award of $2,340,322, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will fund a prospective, multicenter cohort study of 1,268 liver transplant recipients (LTRs) over 2 years, with outcomes tracked up to 5 years post-transplant. The study aims to: Determine the net clinical benefit of blood pressure-lowering on target organs in LTRs, Evaluate if cardiac biomarker levels can improve...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $290,881 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to the Trustees of Indiana University, doing business as Indiana University Indianapolis. The grant, titled "Indiana Stimulating Access to Research in Residency (I-STARR)", aims to train resident-physicians from primary care residency programs in research methods focused on understanding and reducing health disparities in cardiovascular and...
This Project Grant award from the U.S. Department of Health and Human Services Office of Minority Health, under the Community Programs to Improve Minority Health (CFDA 93.137) program, provides $599,959 over 4 years to Wayne State University to address colorectal cancer (CRC) screening and drug overdose (DO) disparities in metro Detroit, Michigan. The key products and services to be delivered include: Partnering with 5 community clinics to implement quality improvement projects to increase CRC...
This Project Grant award of $589,591 from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) supports a study to determine barriers leading to inferior survival for Black and Hispanic patients with Hodgkin lymphoma. The key products/services to be delivered include: Examining differences in the receipt and quality of Hodgkin lymphoma treatment for initial diagnosis and relapse, particularly for patients who have relapsed....
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $792,498 to the Trustees of Indiana University, Indianapolis (IU Indianapolis) to conduct research on hematopoietic stem cells (HSCs) and their regulation under low oxygen tension (hypoxia). The primary goals are to: 1) understand how hypoxia activates the transcription factor TFE3 to facilitate HSC self-renewal, 2) determine...